Cargando…

The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians

BACKGROUND: In shared decision making (SDM), patients and physicians work together to choose the best treatment option for an individual patient. Atopic dermatitis (AD) and psoriasis are particularly suitable for SDM, considering that the best treatment option depends on a patient’s preferences and...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Kraaij, G.E., Vermeulen, F.M., Smeets, P.M.G., Smets, E.M.A., Spuls, P.I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Allergy and Eczema
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818257/ https://www.ncbi.nlm.nih.gov/pubmed/32163645 http://dx.doi.org/10.1111/jdv.16340

Ejemplares similares

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients
por: Roekevisch, E., et al.
Publicado: (2020)

Validation of the Patient‐Oriented SCORing for Atopic Dermatitis tool for black skin
por: Faye, O., et al.
Publicado: (2019)

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial
por: Wollenberg, A., et al.
Publicado: (2021)

Both children and adult patients with difficult‐to‐treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized
por: Boonstra, M., et al.
Publicado: (2018)

The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada
por: de Bruin‐Weller, M., et al.
Publicado: (2020)

Patient‐reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate‐to‐severe atopic dermatitis
por: Thyssen, J.P., et al.
Publicado: (2021)

Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate‐to‐severe atopic dermatitis: an analysis of patient‐reported outcomes
por: Cork, M.J., et al.
Publicado: (2021)

Stepwise approach of development of dermo‐cosmetic products in healthy and atopic dermatitis paediatric population: safety evaluation, clinical development and postmarket surveillance
por: Ribet, V., et al.
Publicado: (2019)

A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy
por: Paller, A.S., et al.
Publicado: (2020)

Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
por: Howells, L., et al.
Publicado: (2019)

A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real‐world study in Belgium
por: Lapeere, H., et al.
Publicado: (2019)

Allergen‐specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy
por: Nothegger, B., et al.
Publicado: (2020)

Burden of chronic urticaria relative to psoriasis in five European countries
por: Balp, M.M., et al.
Publicado: (2017)

Emollient efficacy and acceptability in the treatment of eczematous dry skin: A double-blind, randomised comparison of two UK-marketed products
por: Djokic-Gallagher, Jasmina, et al.
Publicado: (2016)

Relations between a standardized experimental stressor and cutaneous sensory function in patients with chronic pruritus and healthy controls: an experimental case–control study
por: Schneider, G., et al.
Publicado: (2018)

Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need
por: Pereira, M.P., et al.
Publicado: (2018)

Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis
por: Jacob, Minnie, et al.
Publicado: (2021)

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023)

Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists
por: McAleer, Jeremy P.
Publicado: (2023)

Survey of topical exposure concerns for patients and caregivers dealing with atopic dermatitis
por: Ratley, Grace, et al.
Publicado: (2023)

Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic
por: Haddad, Isabelle, et al.
Publicado: (2022)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Online decision aid for patients with psoriasis
por: van der Kraaij, G.E., et al.
Publicado: (2021)

Atopic Dermatitis and Psoriasis as Overlapping Syndromes
por: Bozek, A., et al.
Publicado: (2020)

Effective Primary Prevention of Atopic Dermatitis in High-Risk Neonates via Moisturizer Application: Protocol for a Randomized, Blinded, Parallel, Three-Group, Phase II Trial (PAF Study)
por: Inuzuka, Yusuke, et al.
Publicado: (2022)

A Comparative Analysis of the Predictors, Extent and Impacts of Self-stigma in Patients with Psoriasis and Atopic Dermatitis
por: SCHLACHTER, Sophie, et al.
Publicado: (2023)

Itch in Allergic Contact Dermatitis
por: Lambert, Julien
Publicado: (2021)

Early inhalant allergen sensitization at component level: an analysis in atopic Dutch children
por: Landzaat, Lonneke J., et al.
Publicado: (2023)

Psychosomatic aspects of psoriasis and atopic dermatitis
por: Belugina, Olga
Publicado: (2021)

339 Sensitization to Contactants in Patients with Atopic Dermatitis
por: Matsumoto, Fausto, et al.
Publicado: (2012)

Iron-Deficiency in Atopic Diseases: Innate Immune Priming by Allergens and Siderophores
por: Roth-Walter, Franziska
Publicado: (2022)

Microbe-host interplay in atopic dermatitis and psoriasis
por: Fyhrquist, Nanna, et al.
Publicado: (2019)

Non-atopic Neonatal Thymic Innate Lymphoid Cell Subsets (ILC1, ILC2, and ILC3) Identification and the Modulatory Effect of IgG From Dermatophagoides Pteronyssinus (Derp)-Atopic Individuals
por: de Sousa, Thamires Rodrigues, et al.
Publicado: (2021)

341 Quality of Life in Pediatric Patients with Atopic Dermatitis
por: Campos, Xiomara Lopez
Publicado: (2012)

49 Metallic Soap Aggravates Skin Conditions in Patients With Atopic Dermatitis and a Mouse Model for Human Atopic Dermatitis, NC/TND Mice
por: Tanaka, Akane, et al.
Publicado: (2012)

Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2019)

S100 Proteins in the Pathogenesis of Psoriasis and Atopic Dermatitis
por: Saito-Sasaki, Natsuko, et al.
Publicado: (2023)

Resveratrol ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like lesions through effects on the epithelium
por: Caglayan Sozmen, Sule, et al.
Publicado: (2016)

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
por: Drucker, A.M., et al.
Publicado: (2018)

Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis
por: Frantz, Travis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5jjsfof4nm0cvu6jf6ssvnlckn